Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | XDH | P47989 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14682706 | 0.96 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL1188951 | 0.88 | CA12 (0.68) | CA1CA2CA12CA7CA9 | |
| SCHEMBL12180750 | 0.88 | SLC7A5 (0.49) | CA1CA2CA12CA7CA9 | |
| SCHEMBL21032129 | 0.87 | ALDH1A1 (0.47) | CA1CA2CA12CA7CA9 | |
| SCHEMBL21839916 | 0.87 | CA1 (0.46) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16956840 | 0.87 | CA1 (0.46) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16950320 | 0.84 | SLC7A5 (0.46) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7695307 | 0.84 | KDM4E (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL20043786 | 0.84 | HSD17B10 (0.49) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16950319 | 0.84 | CA12 (0.43) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767281-B2 | Manufacturing and purification technology for high purity Propofol | Chodankar Nandkumar Kashinath (IN) | 2023-09-26 | — | — | US | disclosed |
| US-20230159420-A1 | MANUFACTURING AND PURIFICATION TECHNOLOGY FOR HIGH PURITY PROPOFOL | Chodankar Nandkumar Kashinath (IN) | 2023-05-25 | — | — | US | disclosed |
| EP-4100384-A1 | SIMPLE MANUFACTURING AND PURIFICATION TECHNOLOGY FOR HIGH PURITY PROPOFOL | Chodankar, Nandkumar (IN) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021156776-A1 | SIMPLE MANUFACTURING AND PURIFICATION TECHNOLOGY FOR HIGH PURITY PROPOFOL | CHODANKAR NANDKUMAR (IN) | 2021-08-12 | — | — | WO | disclosed |
| US-8778874-B2 | Glycopeptide antibiotic monomer derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-07-15 | — | — | US | disclosed |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | SHIONOGI & CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159420-A1 | MANUFACTURING AND PURIFICATION TECHNOLOGY FOR HIGH PURITY PROPOFOL | MGMT, SUZ12, U2AF1 | CA1 1644/4885CA2 935/4885CA12 1471/4885 |
| US-11767281-B2 | Manufacturing and purification technology for high purity Propofol | MGMT, SUZ12, U2AF1 | CA1 1644/4885CA2 935/4885CA12 1471/4885 |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | CSGALNACT1, MON2, NR2C2 | CA1 3378/4885CA2 2487/4885CA12 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.